Saturday, November 12, 2016 1:42:00 PM
Very good article giving insight on recent moves in EBIO... without explaining what a 30 minute candle is (;
http://oracledispatch.com/2016/11/10/eleven-biotherapeutics-inc-nasdaqebio-bull-run/
Hold long, hold strong. It's no secret management here is exploring options to maximize shareholder value.. Considering they are the largest stake holders. They have stated in PR exploring sale of company. Current CEO has sold companies before phase 3 results for a tasty premium and that's where EBIO is set up right now.
Recent SESN News
- Carisma Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 08/10/2023 11:30:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM